|
|
|
| home > ebr > spring 2003 > live cells as drug discovery tools - high-throughput, high-content screening |
|
|
 PUBLICATIONS |
European Biopharmaceutical Review
|
| In the drug discovery arena, the better the quality of data, the better the chance of striking 'therapeutic gold'. To bridge the gap from candidate compound to blockbuster drug, the assay should mimic the drug target interactions that occur in a living human cell. Traditional screening practices have been based within the non-cellular environment in order to maximise sample throughput and generate simple one-dimensional data. More recently, the advent of low-throughput, high-content systems have allowed more relevant and complex cell-based assays to be performed. However, cell-based, high-content assays and high-throughput screening need not be mutually exclusive - high-information, high-throughput cell-based technologies are available. A new laser scanning system can provide greater insight into the events occurring at the living cell level and pull low-throughput secondary screening assays into the primary screening stage. |
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
BioPartnering North America™
26-28 February 2012, Vancouver Convention Centre, Vancouver, BC, Canada
BioPartnering North America 2012 (BPN) in Vancouver, Canada brings together senior executives from venture capital firms, major pharmaceutical companies, academic institutions and biotechnology companies of every size from mature to start-up.
More info >> |
|
 |
News and Press Releases |
 |
Pantec Biosolutions to Present P.L.E.A.S.E.® Professional for Transdermal Drug Delivery at DDP in Las Vegas
Pantec Biosolutions AG, the developer and manufacturer of P.L.E.A.S.E.® Professional, a state of the art portable laser device that sets new standards for safety, precision and versatility, today announced that it will be giving a scientific company presentation during the “Drug Delivery Partnerships” conference from 25th -27th January 2012 in Las Vegas, USA.
More info >> |
|
|
